MSX US Stock Daily Observation: Walmart FY2027 Q2 Earnings Report: Revenue and Profit Beat Expectations, US Same-Store Growth Hits Over Six-Year Low

Odaily星球日报Publicado em 2026-08-21Última atualização em 2026-08-21

Resumo

Walmart's FY2027 Q2 earnings report presents a mixed picture. While revenue of $187.9B and adjusted EPS of $0.81 both surpassed consensus estimates, a significant slowdown in the core U.S. business dominated the narrative. U.S. comparable store sales grew only 2.6%, the lowest rate in over six years, missing expectations of 3.5%. The company attributed approximately 125 basis points of this drag to pharmacy price deflation. Despite the weak comps, high-margin segments showed robust growth: global e-commerce rose 23%, global advertising jumped 38%, and the U.S. third-party marketplace surged 52%. Adjusted operating profit growth of 17.4% also outpaced revenue growth, indicating improving profitability. The company raised its full-year guidance for net sales and adjusted EPS. However, the upper end of the new EPS guidance range ($2.87) remains below the market consensus ($2.90). This, coupled with the slowing U.S. comps, signals that growth momentum may be easing. The report highlights a shift in consumer behavior towards more cautious spending, even as transaction volumes remain stable. The key question going forward is whether the rapid expansion of high-margin, non-retail businesses can sufficiently offset the deceleration in core retail growth.

【MSX Research Institute · US Stock RWA Daily Observation】 is a flagship daily report produced by MSX, a leading RWA trading platform. Leveraging our robust macroeconomic research capabilities, we capture the core pulse of the global traditional US stock market, liquidity changes, and the RWA tokenization market to help you strategically position in quality assets.

Today's Observation

Walmart's revenue and adjusted earnings per share (EPS) both beat expectations for the quarter. However, same-store sales growth in its core US market decelerated to its slowest pace in over six years, with pharmacy price deflation being the primary drag. The company raised its full-year sales and profit guidance, but the upper limit of the revised EPS guidance still fell short of market consensus, with signals of slowing growth momentum overshadowing the quarterly beat.

Data at a Glance

FY2027 Q2 total revenue reached $187.9 billion, up 5.9% year-over-year, beating the consensus estimate of $186.77 billion.

Adjusted EPS was $0.81, up 19% year-over-year, beating the consensus of $0.74; but GAAP net income attributable to Walmart was $6.37 billion, down 9% year-over-year, showing divergence between the two measures.

US same-store sales grew only 2.6%, missing the consensus of 3.5% and marking the slowest growth in over six years; the company attributed pharmacy price deflation as a drag of approximately 125 basis points.

By segment: Walmart US net sales were $125.2 billion, up 3.5% YoY; International net sales were $35.2 billion, up 13% YoY; Sam's Club (US) net sales were $25.7 billion, up 8.8% YoY, with comparable sales excluding fuel up 4.4%.

High-margin businesses maintained strong growth: Global e-commerce grew 23% (US +24%); Global advertising grew 38% (Walmart Connect +43%); US third-party marketplace sales grew 52%.

Adjusted operating income was $9.2 billion, up 17.4% on a constant currency basis, outpacing revenue growth.

Full-year guidance was raised across the board: Net sales growth guidance raised from 3.5%-4.5% to 4.0%-5.0%; Adjusted EPS guidance raised to $2.80-$2.87 (from $2.75-$2.85 previously); Adjusted operating income growth guidance is 7.0%-8.5%.

However, the raised EPS guidance upper limit of $2.87 still falls short of the consensus of $2.90. The company noted it has begun receiving tariff refunds this quarter and committed to using these funds to lower product prices.

MSX View

The contradiction in this earnings report lies in the fact that almost every quarterly figure exceeded expectations, while the issues lie in the structure and forward outlook. Revenue, adjusted profit, and operational efficiency all showed improvement: adjusted operating profit growth outpaced revenue growth, and high-margin businesses like advertising, third-party marketplace, and e-commerce all grew at double-digit or higher rates, indicating an improvement in Walmart's profit quality.

US same-store sales growth slowing to a more than six-year low of 2.6% brings the narrative back to a fundamental question: As the broadest-coverage US retailer, its same-store data is a thermometer for consumer health. Pharmacy price deflation explains about 125 basis points, with the remainder pointing to actual changes in consumer behavior. Stable transaction counts but declining average ticket size mean shoppers are still coming, but spending more cautiously.

The fact that full-year guidance was raised across the board yet still fell short of expectations precisely illustrates that market growth expectations for this company have run ahead of the company's own projections. The key going forward is whether the expansion pace of high-margin, non-retail businesses can remain sufficiently strong to offset the slowdown in core retail growth.

About MSX

MSX is a leading RWA trading platform committed to providing secure, efficient, and transparent access to global financial markets. As one of the world's earliest on-chain US stock trading platforms, MSX has consistently been at the forefront of the industry, driving market evolution through continuous innovation.

The platform deeply integrates blockchain technology with compliance frameworks, offering comprehensive trading in spot and derivatives for nearly 400 tokenized stocks and Pre-IPO assets, perfectly bridging the gap between traditional finance and the digital asset industry.

Centered around the core mission of "enabling the free flow of quality assets," MSX has now built a diversified digital financial services ecosystem encompassing US stock spot & perpetual contracts, crypto-to-crypto trading, Pre-IPO, and the MSX Research Institute, aiming to provide global investors with a round-the-clock, high-performance gateway to quality assets.

Official Website: https://msx.com/

Chinese TG:https://t.me/MSXOfficial

Global TG:https://t.me/MSXGlobal

X:https://x.com/MSX_CN

Now available globally on App Store and Google Play.

Risk Warning: Macroeconomic and US stock market volatility is intense. The content of this article is for academic and research observation reference by the MSX Research Institute only and does not constitute any investment advice.

Criptomoedas em alta

Perguntas relacionadas

QDid Walmart's revenue and adjusted earnings exceed or fall short of expectations in FY2027 Q2?

AIn FY2027 Q2, Walmart's revenue and adjusted earnings per share both exceeded market expectations.

QWhat was the key disappointing metric in Walmart's US performance for the quarter, and what was cited as the primary reason for it?

AThe key disappointing metric was US comparable store sales growth, which was only 2.6%, its lowest level in over six years. The company cited pharmacy price deflation as the primary reason, dragging it down by approximately 125 basis points.

QWhich high-margin segments of Walmart's business continued to show strong growth according to the report?

AHigh-margin segments showing strong growth included global e-commerce (up 23%), global advertising business (up 38%), and US third-party marketplace sales (up 52%).

QHow did Walmart revise its full-year guidance following the Q2 results, and did it meet market expectations?

AWalmart revised its full-year guidance upwards for net sales growth and adjusted EPS. However, the upper end of the adjusted EPS guidance ($2.87) still fell short of the market consensus expectation of $2.90.

QAccording to the MSX View analysis, what is the fundamental concern about Walmart's future growth despite the strong quarterly numbers?

AThe fundamental concern is the slowdown in core retail growth, as indicated by the multi-year low in US comparable sales. The future key is whether the expansion speed of high-margin non-retail businesses can continue to be fast enough to offset this core retail slowdown.

Leituras Relacionadas

Unpacking the Truth Behind On-chain Assets: Leverage, Liquidity, and Risk

The article analyzes the concept of "real-world asset" (RWA) tokenization, arguing that while tokenizing assets on-chain is a useful step, it is far from transformative on its own. The author compares it to placing a barcode on a shipping container—it enables identification but does not build the necessary market infrastructure. The core argument is that true value emerges not from tokenization, but from integrating these tokens into DeFi systems where they can be valued, financed, hedged, traded, and liquidated under stress. Key challenges identified include: 1. **Multiple Time Clocks**: A fundamental tension exists between blockchain's 24/7 settlement and the slower, business-hour-dependent processes of traditional markets, custody, and redemption. This "duration mismatch" can create dangerous liquidity gaps during crises. 2. **Liquidity Misconceptions**: True liquidity is not measured by Total Value Locked (TVL) or trading pairs, but by the ability to exit a position within a required timeframe at an acceptable price. It requires analyzing multiple exit paths and stress-testing scenarios. 3. **Leverage and Risk**: Leverage unlocks economic utility (e.g., using tokenized assets as collateral) but also introduces fragility. Risk models must account for more than asset volatility, incorporating factors like legal enforceability, oracle freshness, and market structure. Paradoxically, a "safer" asset like tokenized Treasury bonds could require a higher collateral discount than ETH due to slower, less-proven liquidation mechanisms. 4. **A Risk Graph**: RWA risk should be modeled as a network of interconnected dependencies (e.g., issuers, custodians, oracles, stablecoin pools), not a single score. Failures can propagate through this graph, turning operational issues into systemic liquidity crises. The article states that tokenized government bonds are merely an entry point, while more complex frontiers like computing power and energy assets present greater challenges and opportunities. It also examines the interplay and risks between tokenized stocks and perpetual futures contracts. The conclusion is that the future lies not in "tokenizing everything," but in building robust market layers where tokenized rights become resilient financial primitives within a programmable capital system. The token is just the barcode; the market is the machine.

marsbitHá 1m

Unpacking the Truth Behind On-chain Assets: Leverage, Liquidity, and Risk

marsbitHá 1m

The End of Mathematics: 40 Top Mathematicians Gather at Secret OpenAI Meeting

In August 2026, OpenAI hosted a closed-door summit with approximately 40 leading mathematicians, including recent Fields Medalist Jacob Tsimerman and OpenAI researcher Sébastien Bubeck. The meeting, spurred by a series of recent AI breakthroughs in mathematics, grappled with the potential existential threat AI poses to the field. The backdrop includes several high-profile AI achievements: OpenAI models disproving long-standing conjectures like the unit distance problem, generating 10 new mathematical discoveries, and Anthropic's Claude aiding in constructing complex multidimensional objects. These results often bypass traditional academic pipelines, appearing directly on social media. The mathematical community is divided. Over 3000 researchers signed the "Leiden Statement," advocating for responsible AI use and verification. Others resist AI entirely to preserve human-centric mathematics. A key concern is AI's current inability to *explain* proofs, particularly the difficult steps, which is central to mathematical understanding. At the summit, Bubeck outlined four potential futures: mathematics becoming like collaborative software engineering, a compute-driven field like physics, a curatorial exercise where humans interpret AI output, or a mass transition of mathematicians into AI safety. While emphasizing that "mathematics only makes sense when mathematicians learn from it," no consensus was reached. The event highlights a profound moment of reflection. As AI demonstrates increasing competence in solving complex problems, mathematicians are forced to question their future role and the very meaning of their discipline.

marsbitHá 6m

The End of Mathematics: 40 Top Mathematicians Gather at Secret OpenAI Meeting

marsbitHá 6m

Anthropic's New Models 'Catch the Gossip', The Strongest Fable 5 Unexpectedly Falls Flat

Anthropic has been discovered working on two new, previously unknown models codenamed "Marshmallow" (claude-marshmallow-eap) and "Melon" (claude-melon-eap), with early tests showing Marshmallow potentially surpassing Claude Opus 5 in conversational naturalness. Their emergence coincides with surprising new data revealing that Anthropic's flagship Fable 5 model, released two months ago as its strongest and most expensive offering, is being largely ignored by the enterprise market. According to spending data from Ramp tracking over 70,000 US companies, Fable 5 accounts for only about 11% of total token spending on Anthropic's models. This pales in comparison to OpenAI's flagship GPT-5.6 Sol, which commands roughly 25% of token spending in the same period. The tepid adoption is largely attributed to Fable 5's extremely high cost—double that of Opus 4.8 and ten times that of Haiku 4.5—without delivering proportionally superior performance for most business applications. Compounding the issue, the later-released Claude Opus 5, priced at half the cost of Fable 5, has achieved comparable or even better results in key benchmarks like programming and knowledge work, quickly surpassing Fable 5 in enterprise spending share. Furthermore, the rapid rise of powerful, low-cost open-source models—whose token usage share surged from 11% in April to 62% in August while costing less than 4% of enterprise AI budgets—applies additional pressure. Analysts suggest the sudden appearance of Marshmallow and Melon may be an urgent move by Anthropic to address this gap in its lineup. The goal is to offer models that are not only powerful but also cost-effective enough for businesses to adopt widely and sustainably, moving beyond a flagship that serves more as a showcase than a workhorse.

marsbitHá 6m

Anthropic's New Models 'Catch the Gossip', The Strongest Fable 5 Unexpectedly Falls Flat

marsbitHá 6m

Three Months After the Passing of Little Dog Rosie, Her Medical Records Transformed into an AI Healthcare Company

Three months after the passing of his dog Rosie, AI entrepreneur Paul S. Conyngham secured $4 million in seed funding from Founders Fund for his new startup, Gamgee. The company aims to industrialize the experimental, AI-assisted process he pioneered to create a personalized mRNA cancer vaccine for Rosie, who suffered from mast cell tumors. With no formal biology background, Conyngham used AI tools like ChatGPT and AlphaFold to analyze Rosie's tumor DNA, identify target neoantigens, and design a custom mRNA vaccine sequence. Laboratory partners at UNSW produced the vaccine. Initial treatment showed tumor reduction, but Rosie's cancer later recurred and she was euthanized. Gamgee's goal is to streamline this "N-of-1" approach into a repeatable service for canine cancer patients, handling sequencing, vaccine design, production, and delivery. Clinical trials are planned in Australia in collaboration with research institutions. The company also eyes a longer-term vision of establishing personalized, mRNA-based medicine across species. The story highlights the broader challenge in personalized cancer treatment: compressing the entire timeline from design and regulatory approval to manufacturing and administration to match the patient's prognosis. While AI can accelerate target discovery, the remaining logistical and regulatory hurdles are significant. The article concludes by emphasizing that, for now, consulting qualified veterinary oncologists remains the responsible path for pet owners.

marsbitHá 15m

Three Months After the Passing of Little Dog Rosie, Her Medical Records Transformed into an AI Healthcare Company

marsbitHá 15m

Trading

Spot

Artigos em Destaque

Como comprar BEAT

Bem-vindo à HTX.com!Tornámos a compra de Audiera (BEAT) simples e conveniente.Segue o nosso guia passo a passo para iniciar a tua jornada no mundo das criptos.Passo 1: cria a tua conta HTXUtiliza o teu e-mail ou número de telefone para te inscreveres numa conta gratuita na HTX.Desfruta de um processo de inscrição sem complicações e desbloqueia todas as funcionalidades.Obter a minha contaPasso 2: vai para Comprar Cripto e escolhe o teu método de pagamentoCartão de crédito/débito: usa o teu visa ou mastercard para comprar Audiera (BEAT) instantaneamente.Saldo: usa os fundos da tua conta HTX para transacionar sem problemas.Terceiros: adicionamos métodos de pagamento populares, como Google Pay e Apple Pay, para aumentar a conveniência.P2P: transaciona diretamente com outros utilizadores na HTX.Mercado de balcão (OTC): oferecemos serviços personalizados e taxas de câmbio competitivas para os traders.Passo 3: armazena teu Audiera (BEAT)Depois de comprar o teu Audiera (BEAT), armazena-o na tua conta HTX.Alternativamente, podes enviá-lo para outro lugar através de transferência blockchain ou usá-lo para transacionar outras criptomoedas.Passo 4: transaciona Audiera (BEAT)Transaciona facilmente Audiera (BEAT) no mercado à vista da HTX.Acede simplesmente à tua conta, seleciona o teu par de trading, executa as tuas transações e monitoriza em tempo real.Oferecemos uma experiência de fácil utilização tanto para principiantes como para traders experientes.

521 Visualizações TotaisPublicado em {updateTime}Atualizado em 2026.06.02

Como comprar BEAT

Discussões

Bem-vindo à Comunidade HTX. Aqui, pode manter-se informado sobre os mais recentes desenvolvimentos da plataforma e obter acesso a análises profissionais de mercado. As opiniões dos utilizadores sobre o preço de BEAT (BEAT) são apresentadas abaixo.

活动图片